0.04
0.00%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Vivos
From its filings with the US Securities and Exchange Commission
Vivos is based in Richland, Washington and is incorporated in Delaware. Its shares trade on OTC under the ticker RDGL. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2024, it reported revenue of $4,995.
FDA does not exercise premarket authority over veterinary devices, and manufacturers bear responsibility for ensuring ongoing compliance.
This classification enables the commercial distribution of IsoPet® for treating solid tumors in animals.
Board felt that demonstrating efficacy in clinical trials with this new indication provided a more efficient pathway to regulatory clearance.
These recommendations required substantial effort to incorporate into our next submission.
Recent successful therapies of equine ocular tumors without damaging the eye and human therapy on cancerous nodes directly on the trachea without damaging that organ, confirm the use of Y-90 and may impact the business case of development of alternate isotopes.
Our trademarks include BetaGel and AlphaGel and our provisional patents cover the isotopes P-32, Lu-177, and Ac-225. Depending on the business case conclusions, over the next three years we intend to conduct laboratory testing and then animal and finally human studies in India.
January 2025, the Company filed an additional provisional patent related to PrecisionGel™.
Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Aug 2001
- Employees
- 10
- Website
- radiogel.com ↗
- Head office
- 719 JADWIN AVENUE, RICHLAND, WA, 99352
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Dr. Carlton CadwellNon-Executive Independent Chairman of the Board, Secretary, since 2006
- Mr. Brad WeeksPresident
- Dr. Michael KorenkoChief Executive Officer, Director, since 2009$335,500
- Mr. Michael PollackInterim Chief Financial Officer
- Mr. David SwanbergChief Operating Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Vivos Inc possesses several strengths which contribute to its competitive advantage in the market. Firstly, the company has a strong and experienced management team that demonstrates exemplary leadership and industry knowledge. This allows them to make informed decisions and navigate through challenges effectively.
- Secondly, Vivos Inc has developed innovative and cutting-edge technological solutions that differentiate it from its competitors. These solutions provide unique features and benefits to customers, attracting a loyal customer base and enhancing the company's brand reputation.
Weaknesses
- Despite its strengths, Vivos Inc also faces certain weaknesses that need to be addressed. One of these weaknesses is its dependence on a single supplier for a critical component of its products. Any disruption or issue with this supplier could impact the company's ability to deliver its products to customers on time, leading to potential customer dissatisfaction and revenue loss.
- Additionally, the company should strive to diversify its product portfolio to reduce reliance on a single product line. This will mitigate the risk of market fluctuations or advancements in competing technologies that could render their products obsolete.
Opportunities
- Vivos Inc has several opportunities to explore and capitalize on in the market. The increasing global demand for their core product presents an opportunity for the company to expand its market share and generate higher revenues. Furthermore, the growing emphasis on sustainable and eco-friendly solutions makes Vivos Inc well-positioned to cater to this market segment, offering products with less environmental impact.
- Collaboration with strategic partners or industry leaders can provide Vivos Inc access to new markets, distribution channels, and resources. This will enable the company to expand its reach and enhance its competitive position in the industry.
Threats
- Vivos Inc faces certain threats that may hinder its growth and success in the market. One major threat is the potential entry of new competitors with similar or better technological solutions. This could lead to intensified market competition, price pressure, and a potential decline in market share.
- Moreover, changes in regulations or government policies pertaining to the industry may pose challenges to Vivos Inc's operations. Compliance with new regulations and associated costs can impact the company's profitability and sustainability if not managed effectively.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.